Frankfurt - Delayed Quote • EUR
LungLife AI, Inc. (9H4.F)
At close: April 26 at 3:29 PM GMT+2
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
37.0000
24.0000
195.0000
205.1800
Cost of Revenue
--
--
96.0000
188.1780
Gross Profit
37.0000
24.0000
99.0000
17.0020
Operating Expense
5,603.0000
7,148.0000
5,443.0000
3,741.6380
Operating Income
-5,566.0000
-7,124.0000
-5,344.0000
-3,724.6360
Net Non Operating Interest Income Expense
142.0000
36.0000
-405.0000
-777.1860
Pretax Income
-5,938.0000
-7,602.0000
-7,428.0000
-4,839.0230
Tax Provision
6.0000
4.0000
16.0000
--
Net Income Common Stockholders
-5,944.0000
-7,606.0000
-7,444.0000
-4,839.0230
Diluted NI Available to Com Stockholders
-5,944.0000
-7,606.0000
-7,444.0000
-4,839.0230
Basic EPS
-0.23
-0.30
-0.47
-0.19
Diluted EPS
-0.23
-0.30
-0.47
-0.19
Basic Average Shares
25,484.3960
25,481.8000
15,870.1430
25,480.7900
Diluted Average Shares
25,484.3960
25,481.8000
15,870.1430
25,480.7900
Total Operating Income as Reported
-6,182.0000
-7,740.0000
-7,229.0000
-4,061.8370
Total Expenses
5,603.0000
7,148.0000
5,539.0000
3,929.8160
Net Income from Continuing & Discontinued Operation
-5,944.0000
-7,606.0000
-7,444.0000
-4,839.0230
Normalized Income
-6,052.7500
-7,714.7500
-6,257.5000
-4,501.8220
Interest Income
189.0000
88.0000
12.0000
--
Interest Expense
47.0000
52.0000
417.0000
777.1860
Net Interest Income
142.0000
36.0000
-405.0000
-777.1860
EBIT
-5,891.0000
-7,550.0000
-7,011.0000
-4,061.8370
EBITDA
-5,636.0000
-7,265.0000
-6,688.0000
-3,779.1830
Reconciled Cost of Revenue
--
--
96.0000
188.1780
Reconciled Depreciation
255.0000
285.0000
323.0000
282.6540
Net Income from Continuing Operation Net Minority Interest
-5,944.0000
-7,606.0000
-7,444.0000
-4,839.0230
Total Unusual Items Excluding Goodwill
145.0000
145.0000
-1,582.0000
-337.2010
Total Unusual Items
145.0000
145.0000
-1,582.0000
-337.2010
Normalized EBITDA
-5,781.0000
-7,410.0000
-5,106.0000
-3,441.9820
Tax Rate for Calcs
0.0003
0.0003
0.0003
--
Tax Effect of Unusual Items
36.2500
36.2500
-395.5000
--
12/31/2020 - 1/5/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade